ELV
Elevance Health, Inc.
Stock
$386.43+4.76 (+1.25%)Close Oct 2, 2026
Cash flow statement
| Line | Last 12 months | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $7.5B | $4.3B | $5.8B | $8.1B | $8.4B | $8.4B | $10.7B | $6.1B | $3.8B | $4.2B | $3.3B | $4.2B | $3.4B | $3.1B | $2.7B | $3.4B | $1.4B | $3.0B | $2.5B | $4.3B |
| Capital expenditures | $1.2B | $1.1B | $1.3B | $1.3B | $1.2B | $1.1B | $1.0B | $1.1B | $1.2B | $791M | $584M | $638M | $715M | $647M | $545M | $520M | $451M | $378M | $346M | $322M |
| Free cash flow | $6.3B | $3.2B | $4.6B | $6.8B | $7.2B | $7.3B | $9.7B | $5.0B | $2.6B | $3.4B | $2.7B | $3.6B | $2.7B | $2.4B | $2.2B | $2.9B | $965M | $2.7B | $2.2B | $4.0B |
| Stock-based compensation | $244M | $276M | $191M | $289M | $264M | $255M | $283M | $294M | $226M | $170M | $165M | $148M | $169M | $146M | $147M | $135M | $136M | $154M | $156M | $177M |
| Buybacks | $2.7B | $2.6B | $2.9B | $2.7B | $2.3B | $1.9B | $2.7B | $1.7B | $1.7B | $2.0B | $0 | $1.5B | $3.0B | $1.6B | $2.5B | $3.0B | $4.4B | $2.6B | $3.3B | $6.2B |
| Dividends paid | $1.5B | $1.5B | $1.5B | $1.4B | $1.2B | $1.1B | $954M | $818M | $776M | $705M | $684M | $657M | $481M | $448M | $367M | $358M | $0 | — | — | — |
| Dividends per share | $6.87 | — | — | $5.92 | $5.12 | $4.52 | $3.80 | $3.20 | $3.00 | $2.70 | $2.60 | $2.50 | $1.75 | $1.50 | $1.15 | $1.00 | $0.00 | — | — | — |
| Free cash flow margin | 3.1% | 1.6% | 2.6% | 3.9% | 4.6% | 5.2% | 7.9% | 4.8% | 2.8% | 3.8% | 3.2% | 4.5% | 3.6% | 3.4% | 3.6% | 4.7% | 1.6% | 4.1% | 3.6% | 6.6% |